NASDAQ : NTRA
Natera, Inc. — Key statistics
Healthcare · Diagnostics & Research · United States
Last price 410.38 USD (Oct 30, 2026, 3:12 PM EDT) · Market cap 59.15B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 59.72B |
| Enterprise Value | 58.87B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 144.14M |
| Shares Outstanding | 144.14M |
| Shares Change (YoY) | +6.45% |
| Shares Change (QoQ) | +1.26% |
| Owned by Insiders (%) | 2.74% |
| Owned by Institutions (%) | 96.85% |
| Float | 140.13M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 22.06 |
| Forward PS | 19.04 |
| PB Ratio | 32.66 |
| P/TBV Ratio | 45.23 |
| P/FCF Ratio | 709.28 |
| P/OCF Ratio | 261.65 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 21.75 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 699.15 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.00 |
| Quick Ratio | 2.74 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | 2.83 |
| Interest Coverage | -74.72 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -12.54% |
| Return on Assets (ROA) | -8.08% |
| Return on Invested Capital (ROIC) | -10.18% |
| Return on Capital Employed (ROCE) | -13.55% |
| Weighted Average Cost of Capital (WACC) | 12.54% |
| Revenue Per Employee | $440,892 |
| Profits Per Employee | -$31,327 |
| Employee Count | 6,140 |
| Asset Turnover | 1.23 |
| Inventory Turnover | 13.98 |
Taxes
| Measure | Value |
|---|
| Income Tax | -60.36M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.52 |
| 52-Week Price Change | +114.88% |
| 50-Day Moving Average | 377.06 |
| 200-Day Moving Average | 266.14 |
| Relative Strength Index (RSI) | 56.82 |
| Average Volume (20 Days) | 1,572,841 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 5.85M |
| Short Previous Month | 6.36M |
| Short % of Shares Out | 4.06% |
| Short % of Float | 4.18% |
| Short Ratio (days to cover) | 3.13 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 2.71B |
| Gross Profit | 1.77B |
| Operating Income | -285.22M |
| Pretax Income | -252.70M |
| Net Income | -192.35M |
| EBITDA | -224.42M |
| EBIT | -285.22M |
| Loss Per Share | -$1.37 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.09B |
| Total Debt | 238.49M |
| Net Cash | 853.01M |
| Net Cash Per Share | $5.92 |
| Equity (Book Value) | 1.82B |
| Book Value Per Share | 12.68 |
| Working Capital | 1.11B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 228.24M |
| Capital Expenditures | -144.04M |
| Depreciation & Amortization | 60.80M |
| Net Borrowing | n/a |
| Free Cash Flow | 84.20M |
| FCF Per Share | $0.58 |
Margins
| Measure | Value |
|---|
| Gross Margin | 65.23% |
| Operating Margin | -10.54% |
| Pretax Margin | -9.33% |
| Profit Margin | -7.11% |
| EBITDA Margin | -8.29% |
| EBIT Margin | -10.54% |
| FCF Margin | 3.11% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -6.45% |
| Shareholder Yield | n/a |
| Earnings Yield | -0.33% |
| FCF Yield | 0.14% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $416.39 |
| Price Target Difference | 0.50% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 23 |
| Revenue Growth Forecast (3Y) | 23.09% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 19.48 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |